Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 10/20 | 0.82 |
| ▸ | FAAH | O00519 | 1/20 | 0.66 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.58 |
| ▸ | GLP1R | P43220 | 8/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13640755 | 1.00 | NOD1 (0.82) | NOD1FAAHSLC6A5GLP1R | |
| SCHEMBL15002725 | 1.00 | NOD1 (0.82) | NOD1FAAHSLC6A5GLP1R | |
| SCHEMBL12807270 | 1.00 | NOD1 (0.82) | NOD1FAAHSLC6A5GLP1R | |
| SCHEMBL16621423 | 0.98 | NOD1 (0.79) | NOD1FAAHSLC6A5GLP1R | |
| SCHEMBL22479777 | 0.92 | NOD1 (0.80) | NOD1SLC6A5GLP1R | |
| SCHEMBL14728360 | 0.92 | NOD1 (0.80) | NOD1SLC6A5GLP1R | |
| SCHEMBL12296667 | 0.92 | NOD1 (0.80) | NOD1SLC6A5GLP1R | |
| SCHEMBL16620545 | 0.92 | SLC6A5 (0.71) | NOD1FAAHSLC6A5 | |
| SCHEMBL16620543 | 0.92 | SLC6A5 (0.71) | NOD1FAAHSLC6A5 | |
| SCHEMBL24788158 | 0.91 | NOD1 (0.78) | NOD1SLC6A5GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10834951-B2 | Organic compounds | GIVAUDAN S.A. (CH) | 2020-11-17 | — | — | US | claimed |
| CN-105592721-B | Organic compounds | 奇华顿股份有限公司 | 2020-03-17 | — | — | CN | claimed |
| EP-3057449-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2018-02-28 | — | — | EP | claimed |
| US-20170258122-A1 | Organic Compounds | GIVAUDAN S.A. (CH) | 2017-09-14 | — | — | US | claimed |
| EP-3057449-A1 | ORGANIC COMPOUNDS | Givaudan S.A. (CH) | 2016-08-24 | — | — | EP | claimed |
| WO-2015050535-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2015-04-09 | — | — | WO | claimed |
| WO-2015049294-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2015-04-09 | — | — | WO | claimed |
| CN-116926140-A | A fatty acylated amino acid with effect of enhancing or improving food taste, and its preparation method | 华南理工大学 | 2023-10-24 | — | — | CN | disclosed |
| US-10834951-B2 | Organic compounds | GIVAUDAN S.A. (CH) | 2020-11-17 | — | — | US | disclosed |
| CN-105592721-B | Organic compounds | 奇华顿股份有限公司 | 2020-03-17 | — | — | CN | disclosed |
| EP-3057449-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2018-02-28 | — | — | EP | disclosed |
| US-20170258122-A1 | Organic Compounds | GIVAUDAN S.A. (CH) | 2017-09-14 | — | — | US | disclosed |
| EP-3057449-A1 | ORGANIC COMPOUNDS | Givaudan S.A. (CH) | 2016-08-24 | — | — | EP | disclosed |
| WO-2015050535-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2015-04-09 | — | — | WO | disclosed |
| WO-2015049294-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2015-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10834951-B2 | Organic compounds | CBR3, C9, AOC2 | NOD1 1614/4885FAAH 2123/4885SLC6A5 4468/4885 |
| US-20170258122-A1 | Organic Compounds | CBR3, C9, AOC2 | NOD1 1614/4885FAAH 2123/4885SLC6A5 4468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.